Utilization and Costs of Compounded Medications for Commercially Insured Patients, 2012-2013

BACKGROUND: Although compounding has a long-standing tradition in clinical practice, insurers and pharmacy benefit managers have instituted policies to decrease claims for compounded medications, citing questions about their safety, efficacy, high costs, and lack of FDA approval. There are no reliab...

Descripción completa

Detalles Bibliográficos
Autores principales: McPherson, Timothy, Fontane, Patrick, Iyengar, Reethi, Henderson, Rochelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398310/
https://www.ncbi.nlm.nih.gov/pubmed/27015256
http://dx.doi.org/10.18553/jmcp.2016.22.2.172

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398310/
https://www.ncbi.nlm.nih.gov/pubmed/27015256
http://dx.doi.org/10.18553/jmcp.2016.22.2.172

Ejemplares similares